Tailoring β-Cyclodextrin for DNA Complexation and Delivery by Homogeneous Functionalization at the Secondary Face

Ortega‐Caballero, Fernando; Mellet, Carmen Ortiz; Gourriérec, Löic Le; Guilloteau, Nicolas; Giorgio, Christophe Di; Vierling, Pierre; Defaye, J.; Fernández, José Manuel Garcı́a

doi:10.1021/ol802081z

Cited by 58 publications

(36 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Cationic cyclodextrins were also combined with positively charged polyrotaxanes either with a poly(ethyleneoxide)-poly(propyleneoxide) poly(ethyleneoxide)(P(EO)-P(PO)-P(EO)) triblock copolymer, a PEI-b-PEG-b-PEI copolymer, or α,ω-dimethacrylate poly(ethylene glycol) [68]. β-Cyclodextrin can be used as a frame to generate homogeneous sevenfold symmetric polyaminothiourea amphiphiles for NA carriers [72]. This structure provided a useful platform to synthesize glycodendrimer derivatives by the attachment of sugar ligands able to recognize cell surface sugar receptors for targeting purpose [73].…”

Section: Development Of Cyclodextrins For Use In Gene Delivery Systemsmentioning

confidence: 99%

Synthetic vectors for gene delivery: An overview of their evolution depending on routes of administration.

Belmadi

Midoux

Loyer

et al. 2015

Biotechnology Journal

View full text Add to dashboard Cite

Nucleic acid delivery constitutes an emerging therapeutic strategy to cure various human pathologies. This therapy consists of introducing genetic material into the whole body or isolated cells to correct a cellular abnormality or disfunction. As with any drug, the main objective of nucleic acid delivery is to establish optimal balance between efficacy and tolerance. The methods of administration and the vectors used are selected depending on whether the goal of treatment is the production of an active protein; the replacement of a missing or inactive gene; or the combat of acquired diseases, such as cancer or AIDS. In that sense, synthetic vectors represent a valuable solution because they are well characterized, their structure can be fine tuned, and their potential toxicity can be reduced, since toxicity depends on the composition of the formulations. Here we review various synthetic vectors for gene delivery and address the question of their biodistribution as a function of the route of administration. We highlight the modifications to vectors structure and formulations necessary to overcome the major hurdles limiting the effectiveness of nucleic acid therapies.

show abstract

Section: Development Of Cyclodextrins For Use In Gene Delivery Systemsmentioning

confidence: 99%

Synthetic vectors for gene delivery: An overview of their evolution depending on routes of administration.

Belmadi

Midoux

Loyer

et al. 2015

Biotechnology Journal

View full text Add to dashboard Cite

show abstract

“…Sequential exhaustive 2,3-O-allylation (!36), hydroboration (!37), mesylation of the generated primary OH groups (!38), and substitution by cysteamine (!39 to 41) furnished a fully symmetric medusa-shaped multifunctional platform (Scheme 8). [74] By appropriately choosing the length of the acyl chains installed at the primary rim and finely adjusting the phosphate binding avidity of the functional elements at the secondary rim, a gene vector that behaved as efficiently as the skirt-type counterparts in transfection experiments using BNL-CL2 cells were obtained. A complementary strategy, that exploits photochemical addition of mercaptopropionic esters to per-2,3-O-allylated b-CD derivatives, has been reported by Darcy and co-workers.…”

Section: Polycationic Cyclodextrins-pdna Complexes (Cdplexes)mentioning

confidence: 99%

Preorganized, Macromolecular, Gene‐Delivery Systems

Mellet

Benito

Fernández

2010

Chemistry A European J

115

View full text Add to dashboard Cite

Viruses represent a paradigmatic example of multicomponent, self‐organized supramolecular systems specialized in the delivery and replication of their genetic material. Mimicking their functioning by artificial synthetic molecules represents a fantastic challenge that will lead to the future development of gene therapy. This is only possible if general approaches towards the construction of nanoscale vehicles for DNA are developed and the key rules governing their capacity to compact genetic material and its active transport/delivery through cell membranes are understood. In this area of research, synthetic organic chemistry plays an important role by providing tools to create tailor‐made molecules of increasing complexity. Preorganization of functional elements onto macromolecular platforms has the potential to allow control of the self‐assembling behavior of discrete architectures to produce nanometric objects that can be programmed to complex, compact, deliver, and release plasmid DNA in a target cell.

show abstract

“…More recently, monodisperse polycationic CD conjugates with promising pDNA delivery capabilities were prepared by homogeneous functionalization of the CD primary rim (22)(23)(24). Aiming at merging the virtues of both cationic polymers and cationic lipids in a flexible, well defined framework, we have reported a modular synthetic strategy for the preparation of polycationic amphiphilic CDs (paCDs) that allows the installation of different building blocks onto either face of the truncated-cone structure in a sequential and controlled way, offering a unique opportunity for structure-activity relationship (SAR) studies (25)(26)(27) (Figure 1). The pDNA complexing capabilities and in vitro transfection efficiencies of the corresponding pDNA-paCDs complexes (CDplexes) were found to be dependent on the CD decoration pattern.…”

Section: Introductionmentioning

confidence: 99%

Insights in cellular uptake mechanisms of pDNA–polycationic amphiphilic cyclodextrin nanoparticles (CDplexes)

Díaz‐Moscoso

Vercauteren

Rejman

et al. 2010

Journal of Controlled Release

View full text Add to dashboard Cite

have equally contributed to the reported work. Abstr actIt is generally recognized that the major obstacle to efficient gene delivery is cellular internalization and endosomal escape of the DNA. Recently, we have developed a modular strategy for the preparation of well-defined polycationic amphiphilic cyclodextrins (paCDs) capable of complexing and compacting DNA into homogeneous nanoparticles (<70 nm).Since paCDs resemble both cationic polymers and cationic lipids, it is conceivable that the corresponding pDNA-paCD nanoparticles (CDplexes) might use the cell uptake and endosomal escape mechanisms described for both lipoplexes and polyplexes. To verify this hypothesis, we have now investigated the uptake and transfection efficiencies of CDplexes in the presence of several inhibitors of endocytosis, namely chlorpromazine, genistein, dynasore and methylated β-cyclodextrin (MbCD). Our data show that CDplexes obtained from paCD 1, which ranks among the most efficient paCD gene vectors reported up to date, are internalized by both clathrin-dependent (CDE) and clathrin-independent endocytosis (CIE), both processes being cholesterol-and dynamin-dependent. We observed that the largest fraction of gene complexes is taken up via CDE, but this fraction is less relevant for transfection. The smaller fraction that is internalized via the CIE pathway is predominantly responsible for successful transfection. Intr oductionThe successful delivery of therapeutic genes into cells and their availability at the intracellular site of action are crucial requirements for successful gene therapy. During the last decade, under the advent of nanotechnology, a broad diversity of creative materials featuring promising properties for nonviral gene delivery applications has emerged, (1). Cationic polymers and lipids, or their combinations, have shown the ability to bind nucleic acids through electrostatic interactions and condense them into complexes that can be readily internalized by cells (2-3). The gene delivering capabilities of many of these systems have been thoroughly investigated. Yet, drawing firm conclusions that might serve to provide feedback for the design of improved delivery entities is a delicate issue as a consequence of the essentially polydisperse nature of such structures (4).The control of the architecture of multifunctional macromolecules is a major determinant in the rational design of successful nonviral gene delivery systems. Novel 3 strategies have been implemented to build up well defined constructs featuring selfassembling capabilities in the presence of nucleic acids. In this context, the unique characteristics of dendrimers and other highly ordered clusters, such as uniformity, monodispersity and multivalency, have attracted increasing attention (5-8). Homogeneous external functionalization of these platforms becomes, however, exponentially more complicated as the dendrimer generation increases (9-10). The use of preorganized macrocyclic scaffolds, such as calixarenes, to achieve a precise alignment of functiona...

show abstract

Tailoring β-Cyclodextrin for DNA Complexation and Delivery by Homogeneous Functionalization at the Secondary Face

Cited by 58 publications

References 40 publications

Synthetic vectors for gene delivery: An overview of their evolution depending on routes of administration.

Synthetic vectors for gene delivery: An overview of their evolution depending on routes of administration.

Preorganized, Macromolecular, Gene‐Delivery Systems

Insights in cellular uptake mechanisms of pDNA–polycationic amphiphilic cyclodextrin nanoparticles (CDplexes)

Contact Info

Product

Resources

About